JPH09512818A - 口腔衛生組成物 - Google Patents
口腔衛生組成物Info
- Publication number
- JPH09512818A JPH09512818A JP7528882A JP52888295A JPH09512818A JP H09512818 A JPH09512818 A JP H09512818A JP 7528882 A JP7528882 A JP 7528882A JP 52888295 A JP52888295 A JP 52888295A JP H09512818 A JPH09512818 A JP H09512818A
- Authority
- JP
- Japan
- Prior art keywords
- oral hygiene
- chitosan
- heparin
- hygiene composition
- polysaccharides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 229920001661 Chitosan Polymers 0.000 claims abstract description 41
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 35
- 239000005017 polysaccharide Substances 0.000 claims abstract description 35
- 150000004676 glycans Chemical class 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 20
- 241000124008 Mammalia Species 0.000 claims abstract description 7
- 229920000669 heparin Polymers 0.000 claims description 37
- 229960002897 heparin Drugs 0.000 claims description 37
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 29
- 239000000606 toothpaste Substances 0.000 claims description 21
- 229940034610 toothpaste Drugs 0.000 claims description 20
- 239000010408 film Substances 0.000 claims description 19
- 239000000499 gel Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 201000001245 periodontitis Diseases 0.000 claims description 9
- 239000002324 mouth wash Substances 0.000 claims description 7
- 229940051866 mouthwash Drugs 0.000 claims description 7
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 239000011049 pearl Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 5
- 229920000288 Keratan sulfate Polymers 0.000 claims description 5
- 208000002925 dental caries Diseases 0.000 claims description 5
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 5
- 229940051593 dermatan sulfate Drugs 0.000 claims description 5
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 claims description 5
- 229960004291 sucralfate Drugs 0.000 claims description 5
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- -1 chondroitin Polysaccharides Chemical class 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 2
- 229920002567 Chondroitin Polymers 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 28
- 210000000515 tooth Anatomy 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000012153 distilled water Substances 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 229920000609 methyl cellulose Polymers 0.000 description 8
- 239000001923 methylcellulose Substances 0.000 description 8
- 235000010981 methylcellulose Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000005888 Periodontal Pocket Diseases 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003381 deacetylation reaction Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000003239 periodontal effect Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 229920001222 biopolymer Polymers 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000006196 deacetylation Effects 0.000 description 4
- 229960000633 dextran sulfate Drugs 0.000 description 4
- 210000004195 gingiva Anatomy 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 108010023197 Streptokinase Proteins 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 229940045110 chitosan Drugs 0.000 description 3
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000002379 periodontal ligament Anatomy 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000034619 Gingival inflammation Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical group N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.キトサンおよび負に荷電した硫酸化多糖類の生物学的活性量を組み合わせて 含有する口腔衛生組成物。 2.キトサン‐多糖類の重量比が約6:4〜99.5:0.5の範囲に有る請求項1記 載の口腔衛生組成物。 3.多糖類がヘパリン、スクラルファート、コンドロイチン硫酸、デルマタン硫 酸、硫酸ケラタンおよびペントサン硫酸から選択される請求項1または2記載の 口腔衛生組成物。 4.多糖類がヘパリンである請求項3記載の口腔衛生組成物。 5.キトサンおよび多糖類および歯科的に許容される担体を含有する前記請求項 の何れかに記載の口腔衛生組成物。 6.歯用クリーム、練歯磨きまたは粉歯磨きの形態の請求項5記載の口腔衛生組 成物。 7.マウスウオッシュの形態の請求項5記載の口腔衛生組成物。 8.マウススプレーの形態の請求項5記載の口腔衛生組成物。 9.崩壊性フィルムの形態、ゲルの形態、パールの形態または粉末形態の請求項 1〜4の何れかに記載の口腔衛生組成物。 10.前記請求項の何れかの口腔衛生組成物の生物学的活性量を哺乳類に経口投与 することを特徴とするヒトを含む哺乳類における口腔衛生を改善するための方法 。 11.歯周炎、歯垢および/または齲歯の治療のための請求項10記載の方法。 12.歯科的に活性な口腔衛生組成物の製造のための負に荷電した硫酸化多糖類と 組み合わせたキトサンの使用。 13.キトサンが、ヘパリン、スクラルファート、コンドロイチン硫 酸、デルマタン硫酸、硫酸ケラタンおよびペントサン硫酸から選択される多糖類 と組み合わて存在する請求項12記載の使用。 14.キトサンが、ヘパリンと組み合わせて存在する請求項13記載の使用。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9401540A SE518597C2 (sv) | 1994-05-04 | 1994-05-04 | Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies |
| SE9401540-1 | 1994-05-04 | ||
| PCT/SE1995/000476 WO1995030403A1 (en) | 1994-05-04 | 1995-04-28 | Oral hygiene composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09512818A true JPH09512818A (ja) | 1997-12-22 |
| JP3342492B2 JP3342492B2 (ja) | 2002-11-11 |
Family
ID=20393891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52888295A Expired - Fee Related JP3342492B2 (ja) | 1994-05-04 | 1995-04-28 | 口腔衛生組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5711938A (ja) |
| EP (1) | EP0758223B1 (ja) |
| JP (1) | JP3342492B2 (ja) |
| AU (1) | AU687560B2 (ja) |
| CA (1) | CA2189436C (ja) |
| DE (1) | DE69521692T2 (ja) |
| ES (1) | ES2161292T3 (ja) |
| SE (1) | SE518597C2 (ja) |
| WO (1) | WO1995030403A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539233A (ja) * | 1999-03-22 | 2002-11-19 | ヴィルバク | リウマチ障害を一般投与によって予防または治療するための、コンドロイチン硫酸およびキトサンに基づく組成物 |
| JP2004505678A (ja) * | 2000-08-10 | 2004-02-26 | オスファルマ エス.エル. | 高い細胞接着能を有するキトサン系フィルムの製造方法および用途、ならびに該フィルムを被覆した製品 |
| KR20160049960A (ko) | 2014-10-28 | 2016-05-10 | 라이온 가부시키가이샤 | 액상 조성물 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4941297A (en) * | 1996-11-15 | 1998-06-10 | Dumex-Alpharma A/S | A method for promoting tissue repair |
| SE508760C2 (sv) * | 1997-04-29 | 1998-11-02 | Medicarb Ab | Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur |
| DE69806638T2 (de) | 1997-12-22 | 2003-03-13 | Ciba Speciality Chemicals Holding Inc., Basel | Verwendung von polyanionisch und polyanionisch-derivatisiert natürlichen polysacchariden für die inhibierung von alkalischer phosphatase |
| ZA991792B (en) * | 1998-04-29 | 1999-09-16 | Trevor Wasserman | Mouthwash composition. |
| DE19911055A1 (de) | 1999-03-12 | 2000-09-21 | Cognis Deutschland Gmbh | Verwendung von oberflächenaktiven Gemischen |
| DE50014547D1 (de) * | 2000-09-01 | 2007-09-20 | Cognis Ip Man Gmbh | Mund- und Zahnpflegemittel |
| US6536448B2 (en) | 2000-12-29 | 2003-03-25 | Kimberly-Clark Worldwide, Inc. | Hemostat coated dental floss and hemostat coated dental tape |
| US8444958B2 (en) * | 2001-02-28 | 2013-05-21 | Ezaki Glico Co., Ltd. | Compositions having anti-dental caries function |
| US20030108846A1 (en) * | 2001-12-06 | 2003-06-12 | Kimberly-Clark Worldwide, Inc. | Disposable oral hygiene device and methods of making same |
| US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| DE102004043945A1 (de) * | 2004-09-11 | 2006-03-30 | Henkel Kgaa | Mund-, Zahn- und Zahnprotesenpflegemittel enthaltend die Plaquebildung inhibierende Substanzen |
| WO2007031812A1 (en) * | 2005-09-16 | 2007-03-22 | Medipol Sa | Chitosan-based particles |
| CN1939255B (zh) * | 2005-09-30 | 2010-04-21 | 姚春阳 | 一种甲壳素牙膏 |
| US9248079B2 (en) * | 2007-05-07 | 2016-02-02 | Koninklijke Philips N.V. | Method for cleaning dental plaque from teeth using an adherent peelable gel |
| WO2015023226A1 (en) * | 2013-08-16 | 2015-02-19 | Exthera Ab | Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4512968A (en) * | 1982-11-30 | 1985-04-23 | Lion Corporation | Oral compositions |
| SE8302789D0 (sv) * | 1983-05-18 | 1983-05-18 | Andersson A E Bror | Oral tandvardskomposition |
| US5182103A (en) * | 1985-12-09 | 1993-01-26 | Shiseido Company, Ltd. | Magnesium aluminometasilicate coated composite powder and use thereof |
| JPH0684309B2 (ja) * | 1986-03-24 | 1994-10-26 | ライオン株式会社 | 人工唾液組成物 |
| JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| US4767463A (en) * | 1987-04-15 | 1988-08-30 | Union Carbide Corporation | Glycosaminoglycan and cationic polymer combinations |
| US5036056A (en) * | 1987-07-08 | 1991-07-30 | Martin Kludas | Methods for treating damaged corneal, uterine, or cartilage tissue |
| US5055298A (en) * | 1987-12-01 | 1991-10-08 | Chemisches Laboratorium Dr. Kurt Richter Gmbh | Cosmetic composition comprising an extracellular connective tissue matrix |
| US4855128A (en) * | 1988-01-14 | 1989-08-08 | Warner-Lambert Company | Saccharide inhibition of dental plaque |
| GB8803157D0 (en) * | 1988-02-11 | 1988-03-09 | Nat Res Dev | Denture protection |
| US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
| US5049403A (en) * | 1989-10-12 | 1991-09-17 | Horsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
| US5213898A (en) * | 1989-10-12 | 1993-05-25 | Norsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
| US5186936A (en) * | 1990-08-06 | 1993-02-16 | Board Of Trustees Of The University Of Illinois | Packing material for treatment of infections |
| DE4200080A1 (de) * | 1992-01-03 | 1993-09-30 | Reinmueller Johannes | Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung |
| SE9300139L (sv) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Framställning av ett nytt läkemedel |
| US5645844A (en) * | 1995-06-07 | 1997-07-08 | Chitogenics, Inc. | Negatively charged chitosan derivative semiochemical delivery system |
-
1994
- 1994-05-04 SE SE9401540A patent/SE518597C2/sv not_active IP Right Cessation
-
1995
- 1995-04-28 JP JP52888295A patent/JP3342492B2/ja not_active Expired - Fee Related
- 1995-04-28 DE DE69521692T patent/DE69521692T2/de not_active Expired - Lifetime
- 1995-04-28 CA CA002189436A patent/CA2189436C/en not_active Expired - Fee Related
- 1995-04-28 AU AU24585/95A patent/AU687560B2/en not_active Ceased
- 1995-04-28 WO PCT/SE1995/000476 patent/WO1995030403A1/en not_active Ceased
- 1995-04-28 ES ES95918809T patent/ES2161292T3/es not_active Expired - Lifetime
- 1995-04-28 EP EP95918809A patent/EP0758223B1/en not_active Expired - Lifetime
- 1995-04-28 US US08/737,010 patent/US5711938A/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539233A (ja) * | 1999-03-22 | 2002-11-19 | ヴィルバク | リウマチ障害を一般投与によって予防または治療するための、コンドロイチン硫酸およびキトサンに基づく組成物 |
| JP2004505678A (ja) * | 2000-08-10 | 2004-02-26 | オスファルマ エス.エル. | 高い細胞接着能を有するキトサン系フィルムの製造方法および用途、ならびに該フィルムを被覆した製品 |
| KR20160049960A (ko) | 2014-10-28 | 2016-05-10 | 라이온 가부시키가이샤 | 액상 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2189436C (en) | 2002-06-25 |
| CA2189436A1 (en) | 1995-11-16 |
| DE69521692D1 (de) | 2001-08-16 |
| WO1995030403A1 (en) | 1995-11-16 |
| JP3342492B2 (ja) | 2002-11-11 |
| AU2458595A (en) | 1995-11-29 |
| EP0758223A1 (en) | 1997-02-19 |
| SE9401540L (sv) | 1995-11-05 |
| DE69521692T2 (de) | 2001-10-31 |
| AU687560B2 (en) | 1998-02-26 |
| SE9401540D0 (sv) | 1994-05-04 |
| US5711938A (en) | 1998-01-27 |
| ES2161292T3 (es) | 2001-12-01 |
| EP0758223B1 (en) | 2001-07-11 |
| SE518597C2 (sv) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3342492B2 (ja) | 口腔衛生組成物 | |
| EP0404792B1 (en) | Use of sulphated sucrose in preparations for the treatment of teeth and their supporting tissue | |
| US4986981A (en) | Toothpaste having low abrasion | |
| US5709873A (en) | Method of treating conditions of teeth and their supporting tissue | |
| US5158764A (en) | Dentifrice | |
| US7879315B2 (en) | Agent for dissolving dental calculi and dental caries | |
| JPS59225109A (ja) | 口腔内用組成物 | |
| JPH10505859A (ja) | 表面エッチング | |
| CN101365778A (zh) | 清洁组合物 | |
| JPS60501311A (ja) | 経口による歯処置用組成物 | |
| CN116440036A (zh) | 一种修复美白护龈固齿牙膏及其制备方法 | |
| JPH01502111A (ja) | 口腔衛生用医薬 | |
| US9925397B2 (en) | Conditioning composition | |
| EP2392313B1 (en) | Conditioning composition for treatment of mineralised dental and dental implant surfaces | |
| JP2002322075A (ja) | 組成物 | |
| DK169606B1 (da) | Anvendelse af sulfaterede saccharider til fremstilling af præparater, og præparater indeholdende sulfaterede saccharider | |
| CA1336682C (en) | Preparation for treating dental disease | |
| JP2005139201A (ja) | 歯石及びウ蝕部溶解剤 | |
| Adiana | The Effectiveness of Chitosan on Children’s Dental and Oral Health as a Primary Preventive: A Literature Review | |
| CN120168358A (zh) | 一种添加再生蛋白组合物的牙膏及其制备方法 | |
| IL91438A (en) | Preparation for treating dental disease | |
| JP2004091413A (ja) | キトサンオリゴ糖含有齲蝕予防・抑制剤 | |
| IE892739A1 (en) | Preparation for treating dental disease | |
| US20070020200A1 (en) | Therapeutic compositions and methods of use thereof | |
| CN1049608A (zh) | 治疗牙齿及其支撑组织疾患的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080823 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100823 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100823 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120823 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120823 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130823 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |